By focusing on the genes and tests relevant to oncology, Anthology Diagnostics can offer a practical, cost-effective, and efficient molecular profiling and analysis solution for patients and physicians. Although Anthology Diagnostics is currently focused on cancer only, the lab hopes to expand testing to include other diseases in the future.
Cancer is a complex disease requiring comprehensive answers. Only a comprehensive answer will allow medical professionals to make the highest quality care decisions for their patients. At Anthology Diagnostics we analyze both DNA and RNA which gives the best possible answers based on our current knowledge.
Most labs have hundreds of tests that offer only bits and pieces of the answer about their patient’s tumors leaving the treating medical professional to try to put the pieces together. Physicians frequently run out of sample to complete the testing in search of the right answer, leaving them with only partial results to treat their patients. When you have partial answers patients may suffer and get the wrong treatment.
Unlike other labs that only analyze DNA or focus on the whole genome, Anthology Diagnostics performs next-generation genetic sequencing of DNA and RNA that relevant to oncology — providing a complete picture of the biology that drives cancer in a practical, efficient, and cost-effective way.
Combining Anthology Diagnostics’ advanced testing and sequencing technology with high-quality algorithms, AI-based software, and expert interpretation of results allows Anthology Diagnostics to provide a detailed assessment of each patient’s condition by: